Long-term quality of life in patients with acute respiratory distress syndrome requiring extracorporeal membrane oxygenation for refractory hypoxaemia

Table 5 Results of EQ-5D quality of life for The Alfred ARDS survivors who received VV-ECMO: comparing to other ECMO survivors

EQ5D (English v.2 © 2010 EuroQol Group. EQ-5D™ version for Australia)	Current study cohort, n = 15 (EQ5D v2, five-point scale)
Problems with mobility:
None Slight Moderate Severe Unable	7 (47%) 6 (40%) 1 (7%) 1 (7%) 0
Problems with personal care (washing/dressing):
None Slight Moderate Severe Unable	12 (80%) 2 (13%) 1 (7%) 0 0
Problems with usual activities:
None Slight Moderate Severe Unable	6 (40%) 2 (13%) 2 (13%) 0 5 (42%)
Pain/discomfort:
None Slight Moderate Severe Extreme	3 (25%) 5 (42%) 5 (42%) 2 (13%) 0
Anxiety/depression
None Slight Moderate Severe Extreme	5 (42%) 2 (13%) 3 (25%) 3 (25%) 2 (13%)
Overall health status (VAS, 0 to 100) mean ± SD	65.9 ± 18.6

Results are presented as number (%) unless otherwise stated. ARDS, acute respiratory distress syndrome; ECMO, extracorporeal membrane oxygenation; N, number; VAS, visual analogue scale; v1, version 1; v2, version 2; VV, veno-venous.

ISSN: 1364-8535